Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Van der Jeught

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The Journal of Clinical Investigation|April 13, 2018
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancerYunhua Liu, Hanchen Xu, Kevin Van der Jeught, et al.
Clinical and Translational Gastroenterology|June 3, 2024
Stromal-Like Cells Are Found in Peripheral Blood of Patients With Inflammatory Bowel Disease and Correlate With Immune Activation StateAmanda M Honan, Gillian E Jacobsen, Hannah Drum, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 1, 2024
Inhibition of Glutamate-to-Glutathione Flux Promotes Tumor Antigen Presentation in Colorectal Cancer CellsTao Yu, Kevin Van der Jeught, Haiqi Zhu, et al.
Nature Biomedical Engineering|November 2, 2021
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicityZhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, et al.
JCI Insight|May 8, 2020
ST2 as checkpoint target for colorectal cancer immunotherapyKevin Van der Jeught, Yifan Sun, Yuanzhang Fang, et al.
Nature Communications|October 24, 2018
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase IIYujing Li, Yunhua Liu, Hanchen Xu, et al.
Nature Communications|November 11, 2018
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancerYunhua Liu, Jiangsheng Xu, Hyun Ho Choi, et al.
The Journal of Clinical Investigation|September 29, 2020
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentationYuanzhang Fang, Lifei Wang, Changlin Wan, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
MicroRNA-29a enhances and preserves stem-like CD8 T cell differentiation by regulating master epigenetic circuits of exhaustionXuebing Leng, Lance A Buchness, Christine I Rafie, et al.
ACS Nano|September 27, 2018
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory SafetyKevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The Journal of Clinical Investigation|April 13, 2018
Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancerYunhua Liu, Hanchen Xu, Kevin Van der Jeught, et al.
Clinical and Translational Gastroenterology|June 3, 2024
Stromal-Like Cells Are Found in Peripheral Blood of Patients With Inflammatory Bowel Disease and Correlate With Immune Activation StateAmanda M Honan, Gillian E Jacobsen, Hannah Drum, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 1, 2024
Inhibition of Glutamate-to-Glutathione Flux Promotes Tumor Antigen Presentation in Colorectal Cancer CellsTao Yu, Kevin Van der Jeught, Haiqi Zhu, et al.
Nature Biomedical Engineering|November 2, 2021
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicityZhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, et al.
JCI Insight|May 8, 2020
ST2 as checkpoint target for colorectal cancer immunotherapyKevin Van der Jeught, Yifan Sun, Yuanzhang Fang, et al.
Nature Communications|October 24, 2018
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase IIYujing Li, Yunhua Liu, Hanchen Xu, et al.
Nature Communications|November 11, 2018
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancerYunhua Liu, Jiangsheng Xu, Hyun Ho Choi, et al.
The Journal of Clinical Investigation|September 29, 2020
MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentationYuanzhang Fang, Lifei Wang, Changlin Wan, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
MicroRNA-29a enhances and preserves stem-like CD8 T cell differentiation by regulating master epigenetic circuits of exhaustionXuebing Leng, Lance A Buchness, Christine I Rafie, et al.
ACS Nano|September 27, 2018
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory SafetyKevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
Pageof 4